Markt geschlossen -
Andere Börsenplätze
|
% 5 Tage | % 1. Jan. | ||
25.74 USD | -0.35% |
|
-2.94% | -2.98% |
07.02. | US FDA genehmigt AbbVie's Behandlung für intra-abdominale Infektionen | RE |
06.02. | PFIZER, INC. : Daiwa Securities bekräftigt seine Kaufempfehlung | ZM |
Zu einer Liste hinzufügen 0 ausgewählt | Umsatz (Y-1) | Nettogewinn (Y-1) | EBIT-Marge (Y-1) | ROE (Y-1) | ROA (Y-1) | Verschuldungsgrad (Y-1) | |
---|---|---|---|---|---|---|---|
58.5 Mrd. | 3.62% | 15.9% | 11.37% | 4.96% | 3.8x | ||
34.12 Mrd. | 15.36% | 20.68% | 48.93% | 9.23% | 2.6x | ||
40.31 Mrd. | 34.78% | 44.19% | 80.78% | 25.88% | 0.52x | ||
85.16 Mrd. | 41.28% | 32.25% | 34.91% | 14.32% | 0.21x | ||
54.32 Mrd. | 8.95% | 45.64% | 143.18% | 14.46% | 1.82x | ||
66.76 Mrd. | 13.68% | 34.42% | 43.45% | 15.69% | 0.74x | ||
45.81 Mrd. | 13.01% | 31.73% | 29.77% | 11.48% | 1.66x | ||
60.12 Mrd. | 0.61% | 10.33% | 9.18% | 3.56% | 2.77x | ||
50.32 Mrd. | 23.73% | 38.74% | 34.74% | 15.58% | 0.85x | ||
28.19 Mrd. | 23.83% | 47.53% | 202.85% | 12.37% | 3.07x | ||
47.61 Mrd. | 12.54% | 29.42% | 13.65% | 4.27% | 0.55x | ||
27.12 Mrd. | 20.89% | 38.66% | 38.46% | 13.49% | 1.34x | ||
45.01 Mrd. | 17.83% | 37.3% | 51.57% | 8.36% | 1.55x | ||
7.88 Mrd. | 29.29% | 39.52% | 21.3% | 23.34% | -1.57x | ||
38.63 Mrd. | 16.25% | 28.97% | 52.48% | 10.55% | 1.29x | ||
10.59 Mrd. | 12.53% | 13.21% | 12.8% | 7.95% | -2.01x | ||
28.19 Mrd. | 3.38% | 5.02% | 2.1% | 0.36% | 4.66x | ||
14.4 Mrd. | 9.28% | 22.55% | 6.37% | 3.05% | 3.01x | ||
3.22 Mrd. | 18.85% | 21.52% | 10.99% | 9.99% | -3.66x | ||
Durchschnitt | 39.28 Mrd. | percentage-no-prefix | percentage-no-prefix | percentage-no-prefix | percentage-no-prefix | 1.22x | |
Gewichteter Durchschnitt nach Marktkapitalisierung | 46.76 Mrd. | percentage-no-prefix | percentage-no-prefix | percentage-no-prefix | percentage-no-prefix | 1.54x |
- Börse
- Aktien
- 852009 Aktie
- Sektor Pfizer, Inc.
- Finanzielle Vergleiche

MarketScreener is also available in this country: United States.
Switch edition